| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/2004 | US20040072285 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 04/15/2004 | US20040072283 Rapid immunoselection cloning method |
| 04/15/2004 | US20040072282 Preparing g-protein coupled receptor fragment for identifying modulators of signal tranduction and drug therapeutics |
| 04/15/2004 | US20040072270 Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
| 04/15/2004 | US20040072267 Method for simultaneously detecting an antigen of, and and antibody against, an infectious microorganism |
| 04/15/2004 | US20040072265 Using tumor antigen CDNA probes to diagnose and treat brain disorders; antiproliferative/antitumor agents |
| 04/15/2004 | US20040072264 Comprises nucleotide sequences coding ca protein (CAP) for diagnosing and treating cell proliferative disorders; antiproliferative agents |
| 04/15/2004 | US20040072258 Disruption of a Ras-protein complex by a Ras antagonist, e.g.,farensylthiosalicylic acid, analyzed; identifying drug candidates inhibiting aberrant Ras activity; binding andinactivating mRNA of anchor protein by a oligonucleotides |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072254 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds |
| 04/15/2004 | US20040072240 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072234 High affinity nucleic acid ligands to lectins |
| 04/15/2004 | US20040072229 Comprises nucleotide sequences coding ligand binding membrane protein for identifying modulator for treatment of kidney, neural, pancreatic or prostate diseases |
| 04/15/2004 | US20040072228 Comprises nucleotide sequences coding polypeptide with caspase recruitment domain 11 (CARD11) and modulatory activity associated with nuclear factor kapa beta for treating autoimmune and/or lymphoma disorders |
| 04/15/2004 | US20040072227 Integrin ligand, human mindin |
| 04/15/2004 | US20040072224 Comprises therapeutic polypeptide for prevention and treatment of mycobacterial infections, cancers and immunological disorders gene and immunotherapy |
| 04/15/2004 | US20040072222 A conformational model of linear epitope sequence from guinea pig MBP72-85 and human MBP87-99 |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040072216 Methods and compositions for treating and diagnosing diabetes |
| 04/15/2004 | US20040072214 Novel glycoproteins and methods of use thereof |
| 04/15/2004 | US20040072210 Reagents and methods useful for detecting diseases of the breast |
| 04/15/2004 | US20040072207 Comprises nucleotide sequences coding active agent associated with cell cycle signaling and mammalian target of rapamycin (mTOR) protein activity for diagnosis and treatment of cancer |
| 04/15/2004 | US20040072196 Novel serpentine transmembrane antigens expressed in human cancers and uses therefor |
| 04/15/2004 | US20040072194 Vasodilation polypeptide for diagnosis and treatment of vascular and cardiovascular system disorders |
| 04/15/2004 | US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072187 Comprises nucleotide sequences coding biogenic amine receptor for diagnosis, prevention and treatment of parkinson's, schizophrenia, attention deficit hyperactivity disorder |
| 04/15/2004 | US20040072185 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 04/15/2004 | US20040072183 Comprises biodegradable bioahesive polypeptide exhibiting von willebrand factor like protein domains for use in moist conditions, wound healing and plastic surgery; sutures |
| 04/15/2004 | US20040072180 Dna binding peptide domains and a method for providing domains of this type |
| 04/15/2004 | US20040072178 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producng protein capable of regenerating luciferin |
| 04/15/2004 | US20040072173 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040072170 Using creatine kinase messenger RNA expression profiles to diagnose congestive heart failure |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072163 Comprises polynucleotide coding cell death regulatory proteins for diagnosis, prevention and treatment of tumors, tissue necrosis, autoimmune, skin and nervous system disordere |
| 04/15/2004 | US20040072162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 04/15/2004 | US20040072161 Haplotypes of the F2RL1 gene |
| 04/15/2004 | US20040072159 Bzip type transcription factors regulating the expression of rice storage protein |
| 04/15/2004 | US20040072157 Heterotrimeric fusion protein comprising g protein coupled receptor specificity for identifying modulators and treatments of aberrent signal transduction |
| 04/15/2004 | US20040072154 Novel compositions and methods for cancer |
| 04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 04/15/2004 | US20040072146 Using peptide modulator to prevent associations between adenine nucleotide translocator (ANT) and viral replication proteins (VPR); antiapoptosis |
| 04/15/2004 | US20040071787 Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071737 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 04/15/2004 | US20040071733 Baculovirus vector vaccine |
| 04/15/2004 | US20040071731 Chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 04/15/2004 | US20040071730 Polypeptides and polynucleotides; genetic engineering; medical diagnosis |
| 04/15/2004 | US20040071729 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides |
| 04/15/2004 | US20040071728 Vaccine for congenital tremors in pigs |
| 04/15/2004 | US20040071726 Presenting mammalian antigen-presenting cell (APC) cell line transfected with DNA encoding polypeptide; isolating class II major histocompatability complex(MHC) molecule bound to peptide; elution; classification; cancer diagnosis |
| 04/15/2004 | US20040071725 Administered with target antigens to treat infections; anticarcinogenic and antitumor agents; genetic engineering |
| 04/15/2004 | US20040071724 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071723 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071722 Heat shock protein-based vaccines and immunotherapies |
| 04/15/2004 | US20040071721 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071720 A fusion protein of antigen and heat shock protein; DNA therapy promoting gene expression in mammal cells, treating infectious diseases and cancers, tumors; polynucleotide construct vectors |
| 04/15/2004 | US20040071717 Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereof |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071713 A protein is obtained from gene expression of Pseudomonas aeruginosa, molecular weight range from 13 kDa to 80 kDa, purification, antibody, immunization with vaccine antigens, treating bacterial infections |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071708 Bioassay, drug screening a binding protein specifically binding G-protein coupled receptor; identifying anticancer agent, antibody |
| 04/15/2004 | US20040071703 A mixture comprising decorin binding protein and fibronectin binding protein, for treating Lyme disease in animal |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071695 Novel g-protein coupled receptor |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | US20040071690 High avidity polyvalent and polyspecific reagents |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | US20040071673 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 04/15/2004 | US20040071670 Transplantation cell kits for re-myelination of nerve cells |
| 04/15/2004 | US20040071660 Fiber protein of seretype 11, 16, 35, 40 and/or 51; efficient transduction; nucleic acid transfer |
| 04/15/2004 | US20040071659 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | DE10246740A1 Catalyst composition, useful for metal-catalyzed reactions e.g. asymmetric hydrogenation, comprises protein and interacting catalytic unit that includes a transition metal |
| 04/15/2004 | DE10246329A1 New receptor protein, useful for detecting specific-binding aldehydes or their antagonists that can be used as contraceptives and conception-promoting agents |
| 04/15/2004 | DE10246125A1 Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren Concentrate of factor VIII: C-containing von Willebrand factor and the associated method |
| 04/15/2004 | CA2505132A1 Method for screening modulators of mitochondrial fuctionning and new modulators obtained |
| 04/15/2004 | CA2501958A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 04/15/2004 | CA2501040A1 Genetically engineered toxoplasma gondii p30 antigen, improved antigen cocktail and uses thereof |
| 04/15/2004 | CA2501010A1 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 04/15/2004 | CA2500962A1 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | CA2500960A1 Therapeutic uspa1-derived peptides |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | CA2500883A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | CA2500861A1 Method for diagnosing prostate cancer |
| 04/15/2004 | CA2500859A1 Genes and polypeptides relating to prostate cancers |
| 04/15/2004 | CA2500731A1 Methods for controlling proliferation of cells |
| 04/15/2004 | CA2500715A1 Hla binding peptides and their uses |
| 04/15/2004 | CA2500687A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/15/2004 | CA2500673A1 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | CA2500669A1 Products for regulating the degradation of collagen and methods for identifying same |
| 04/15/2004 | CA2500626A1 Interferon variants with improved properties |
| 04/15/2004 | CA2500482A1 Method for diagnosing pancreatic cancer |